Commence wins a prime spot on the $3.5B CMS RMADA 3 IDIQ, expanding its role in federal health policy research and model evaluation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results